Endocrinology

Staff scientists at the US Food and Drug Administration (FDA) have concluded that there's no "convincing evidence" linking testosterone replacement therapy with adverse cardiovascular events.

A new study showing significant negative correlation between phthalate absorption and testosterone levels adds considerably more weight and significant new details to a growing body of research.

A new test recently approved by the US Food and Drug Administration could go a long way in helping identify patients who could suffer acute kidney injury following hospitalization.

The anion gap is extremely useful in the detection and analysis of metabolic acidosis and also intoxicants and some hematologic conditions.

Drug formerly known as Zerenex gets approval following Phase 3 clinical trials

Patients diagnosed with type 1 diabetes are at higher risk for developing major health complications but up until now there had been no reliable way to determine which complications a patient might develop or how severe they might be.

The end of September will mark the deadline set for hospitals across the country to reach Stage 2 of the Meaningful Use program for the year and that means the clock is ticking for health care professionals around the country to meet the goals set for them.

A healthy metabolic profile in the absence of diabetes risk factors does not protect young adult men from incident diabetes associated with overweight and obesity.

A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.

On June 7, 2014, the state of Missouri passed State Bill 716, a piece of legislation creating a new category of health care provider in the state, known as the, "Assistant Physician."

Revised guidelines recommend athletes to drink when they are thirsty and to supplement post-training fluids with "recovery foods."

Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.

Do any of these 5 most common unexpected insurance denials (for June 2014) look familiar to you? Any of the top 5 reason codes? If so, is it time to look into why?

Although hemodialysis is a commonly used treatment for kidney failure, a recent study has shown it may not be as beneficial for people who develop a sudden case of the condition.

Insulin, a peptide hormone, can protect the cells of the pancreas from acute pancreatitis – a disease for which there is currently no cure, according to a study by scientists from The University of Manchester.

Researchers in Great Britain and Australia believe they have found a commonality that could help the treatment of two types of diabetes.

According to the results of a recent study, hospitalized patients may be able to know well in advance whether they are at risk of being diagnosed with type 2 diabetes in the future.

Researchers have manufactured a peptide aimed to block modified proteins associated with Alzheimer's disease, Parkinson's disease, heart disease, type 2 diabetes, Lou Gehrig's disease, and other conditions.

Diabetic neuropathic pain can be controlled with a low-fat vegan diet, according to research presented at the American Association of Diabetic Educators Annual Meeting.

Patients diagnosed with thyroid disease often use it as an explanation or excuse for neuropsychiatric symptoms; this is a form of "labeling effect."

The US Food and Drug Administration recently announced the approval of the KRONUS Zinc Transporter 8 Autoantibody (ZnT8Ab) ELISA Assay, a new test for type 1 diabetes.

Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.

An emerging epidemic of acute hepatitis C threatens the country's younger population, which experienced a significant hike in the number of cases during a recent 6-year period, according to a compound study that looked at trends of the disease among youth.

A new drug was given tentative approval by the US Food and Drug Administration to help patients with both type 1 and type 2 diabetes.

New research finds that people with atrial fibrillation (AF) who undergo radiofrequency ablation and maintain sinus rhythm are less likely than those who opt against the procedure to die of heart attack or heart failure.

Fixed-dose tablet is the first sodium glucose cotransporter 2 (SGLT2) inhibitor plus metformin combo product to receive approval in the US.

Although variouis contraceptives are available for women whose baseline health is good, women who have chronic medical conditions have unique concerns.

Just 6% of individuals with pancreatic cancer live 5 years after diagnosis, and almost half of newly diagnosed pancreatic cancer presents as new-onset diabetes mellitus.

Despite hesitation from patients and other barriers in the healthcare industry, clinicians should encourage patients with type 2 diabetes to switch to insulin much earlier in the disease.

The Endocrine Society and the American Association of Clinical Endocrinologists have released a list of 5 unnecessary tests and procedures as part of the Choosing Wisely project.